Stockwinners Market Radar for December 24, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

14:03 EST Volato resolves noncompliance with NYSE - Volato announced it received from NYSE a warning letter as provided under Section 1009(a) of the NYSE company guide describing the company's failure to comply with Sections 301 and 713 of the company guide. Section 301 of the company guide prohibits a listed company from issuing, or authorizing its transfer agent or registrar to issue or register, additional securities of a listed class until it has filed an application for the listing of such additional securities and received notification from the NYSE American that the securities have been approved for listing. Section 713 of the company guide requires stockholder approval when additional shares to be issued in connection with a transaction involve the sale, issuance, or potential issuance of common stock equal to 20% or more of outstanding stock for less than the greater of book or market value of the stock. As noted in the letter, the company issued approximately 16M shares of Class A common stock between November 2024 and December 2024 pursuant to a settlement agreement and stipulation Dated November 4, that NYSE has determined were in violation of these provisions. The company is implementing additional controls to avoid violations of such NYSE rules in the future. The company has been advised by NYSE that, following the filing of this press release and the associated current report on Form 8-K, this matter is resolved.

13:16 EST CorVel announces effectiveness of three-for-one forward stock split - CorVel Corporation announced the effectiveness of a three-for-one forward stock split, along with a proportionate increase in the number of authorized shares of its common stock to accommodate the stock split. As a result of the stock split, every one share of common stock outstanding or held in treasury on December 23, the record date for the stock split, was split into three shares of common stock. The additional shares of common stock are expected to be distributed on December 24. Trading is expected to begin on a post-stock split adjusted basis at market open on December 26.

12:00 EST MultiPlan rises 65.4% - MultiPlan is up 65.4%, or $4.11 to $10.39.

12:00 EST a.k.a. Brands falls -6.2% - a.k.a. Brands is down -6.2%, or -$1.32 to $20.02.

12:00 EST Vince Holding falls -19.2% - Vince Holding is down -19.2%, or -96c to $4.04.

11:39 EST Mars Acquisition Corp. trading resumes

11:33 EST Nvni Group Ltd trading halted, volatility trading pause

11:18 EST Chenghe Acquisition I Co trading resumes

10:43 EST Bruker 'respectfully disagrees' with District Court, to seek stay of injunction - Bruker (BRKR) earlier today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx Digital Spatial Profiler products sold by its NanoString (NSTG) business. "Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement case between NanoString and 10x Genomics. In its ruling, the District Court upheld the jury's damages award of approximately $31.6 million plus interest and a damages true-up for GeoMx sales since the November 2023 verdict, while declining 10x's request for enhanced damages and attorneys' fees. The Court stated that it would grant 10x's request for an injunction against GeoMx products in the United States, while noting that the proposed injunction includes a carve out for sales of consumables to the installed base of GeoMx customers existing as of the November 2023 verdict in order for them to complete their ongoing research. Further details regarding any injunction and applicable carve outs are expected to be clarified in the coming weeks. The ruling does not impact the CosMx or nCounter product lines, which Bruker also acquired from NanoString in its asset purchase transaction of May 2024. GeoMx instrument revenue represent less than 0.2% of Bruker's total revenue," Bruker stated. Todd Garland, President of the Bruker Spatial Biology division, added: "We respectfully disagree with the District Court's decision to grant an injunction with respect to sales of GeoMx products to new customers in the United States and we expect to promptly seek a stay of any injunction that is finally ordered. We also look forward to the appeal of our case being heard by the U.S. Court of Appeals for the Federal Circuit, a court that specializes in patent disputes. We remain steadfast in our view that the patents that were licensed by 10x and asserted against us are invalid and describe a fundamentally different method than what is used by the GeoMx system. We strongly believe that we should be vindicated on appeal. Bruker remains dedicated to ensuring that the scientific community has the freedom to select the best spatial biology platforms to advance their research."

10:36 EST American Airlines says resolved vendor issue that briefly affected flights - American Airlines stated in a post to its official X account: "We have resolved a vendor technology issue that briefly affected flights this morning. We sincerely apologize to our customers for the inconvenience and have issued a travel alert to allow for additional flexibility." Reference Link

10:09 EST Churchill Capital Corp trading resumes

10:00 EST Natuzzi rises 20.2% - Natuzzi is up 20.2%, or 81c to $4.81.

10:00 EST NeueHealth rises 67.0% - NeueHealth is up 67.0%, or $2.89 to $7.20.

10:00 EST Summit Bancshares falls -9.1% - Summit Bancshares is down -9.1%, or -$1.09 to $10.94.

09:51 EST Portage Biotech trading resumes

09:48 EST China Yuchai rises 18.5% - China Yuchai is up 18.5%, or $1.71 to $10.97.

09:48 EST Nuscale Power falls -3.9% - Nuscale Power is down -3.9%, or -77c to $18.96.

09:47 EST Direct Digital Holdings Inc trading resumes

09:46 EST Portage Biotech trading halted, volatility trading pause

09:32 EST Achilles Therapeutics sells technology assets to AstraZeneca for $12M - Achilles Therapeutics (ACHL) announced that it has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to AstraZeneca (AZN). TRACERx, led by Professor Charles Swanton at University College London, UK, is one of the largest tumor evolution studies to generate deep sequencing multi-region and multi-time-point genetic data from over 3,200 tumor samples from over 800 lung cancer patients. As part of the transaction, AstraZeneca will also take over as sponsor of Achilles' Material Acquisition Platform, and receive tumor samples and data collected thus far. MAP is a proprietary network that has collected donor tumor tissue and blood from nearly 300 cancer patients undergoing standard-of-care cancer surgery across multiple solid tumor indications, including lung, melanoma, head and neck, renal, bladder, and breast. AstraZeneca has agreed to pay Achilles Therapeutics $12M for the assets in total.

09:20 EST Power Solutions announces uplisting to Nasdaq Stock Market - Power Solutions International announced that The Nasdaq Stock Market has approved its application for uplisting the Company's common stock to Nasdaq. PSI's common stock is expected to commence trading on Nasdaq at the opening of the market on December 26, 2024, under the Company's current ticker symbol "PSIX."

09:08 EST Brandywine Realty generates $137M of asset sales - Brandywine Realty Trust announced the completion of two significant sales within joint venture portfolio: 4040 Wilson, a mixed-use development in Arlington, VA, and the Dabney and Brittons Hill portfolio in Richmond, VA. These transactions yielded combined gross sale proceeds of $265.8M, advancing Brandywine's strategic objectives to improve its competitive position, reduce forward capital commitments, and generate incremental liquidity for future investments. 4040 Wilson, located in Arlington's Ballston submarket, was sold for $190.5M. The property has 405,000 square feet of office, retail, and residential space, as well as 494 parking spaces. 4040 Wilson was 96% leased and 94% leased at the time of sale. The Dabney and Brittons Hill portfolio, representing 14 industrial/flex buildings totaling 643,000 square feet, was sold for $66.8M, generating approximately $15.5M of net proceeds to Brandywine for its 50% ownership interest. In connection with the sale, Brandywine sold an 11-acre land parcel operating under a long-term parking lease valued at $8.5M. The assets were fully leased at closing. Together with previously disclosed asset sales, the Company has generated gross sales proceeds of approximately $310M and $191M of net cash proceeds. The proceeds from these transactions will further strengthen Brandywine's balance sheet and support reinvestment in strategic initiatives that align with the company's vision and market strategy.

09:02 EST Siyata Mobile announces 1-for-10 reverse stock split - Siyata Mobile announced that it will effect a 1-for-10 reverse stock split of its common share. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Friday, December 27, and the company's common share will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on December 27. The company's common share will continue to trade on the Nasdaq Capital Market under the company's existing trading symbol, "SYTA," and a new CUSIP number 83013Q 889 has been assigned as a result of the reverse stock split.

08:35 EST Jet.AI launches 'Ava' AI model for private jet booking - Jet.AI announced the launch of its agentic AI model, "Ava," who books private jets. Customers can now conveniently book private jets by calling or texting +1-888-492-4538, where the AI provides real-time aircraft availability, transparent pricing, and expert guidance to help users select the perfect jet for their journey. For those who prefer texting, Ava enables full conversational experience via SMS, responding to inquiries, sharing details, and providing a direct link to the CharterGPT app for seamless trip management. The AI ensures every customer receives a personalized and efficient experience, whether they're seasoned flyers or first-time travelers. This announcement coincides with significant updates to the CharterGPT private jet booking app, including: Enhanced Push Notifications: Stay updated with real-time changes to travel reservations; Carbon Tracking and Offsetting: Empowering travelers to make eco-conscious decisions directly within the app; Deep Linking for Trip Sheets: Ava can conclude a text conversation by providing a link that automatically opens the CharterGPT app, where the traveler can access the discussed trip.

08:19 EST USTR initiates Section 301 investigation on China's semiconductor 'targeting' - United States Trade Representative Katherine Tai announced the initiation of an investigation regarding China's "acts, policies, and practices related to targeting of the semiconductor industry for dominance." The investigation will be conducted under Section 301 of the Trade Act of 1974, as amended. "Evidence indicates that China seeks to dominate domestic and global markets in the semiconductor industry and undertakes extensive anticompetitive and non-market means, including setting and pursuing market share targets, to achieve indigenization and self-sufficiency. China's acts, policies, and practices appear to have and to threaten detrimental impacts on the United States and other economies, undermining the competitiveness of American industry and workers, critical U.S. supply chains, and U.S. economic security," the USTR stated. "This investigation underscores the Biden-Harris Administration's commitment to standing up for American workers and businesses, increasing the resilience of critical supply chains, and supporting the unparalleled investment being made in this industry," said Ambassador Katherine Tai. Publicly traded companies in the semiconductor space include AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN). Reference Link

08:03 EST Ostin Technology updates effective data of reverse share split - Ostin Technology Group announced an update to the effective date of its previously approved reverse share split of the Company's Class A ordinary shares, with the split ratio set at 1-for-10. The Reverse Share Split was approved by the Company's shareholders at an extraordinary general meeting held on November 25, 2024. The effective date for the Reverse Share Split has been revised from December 26, 2024 to December 31, 2024 and the Company's Class A ordinary shares will begin trading on an adjusted basis, reflecting the Reverse Share Split, on December 31, 2024, under the existing ticker symbol "OST." The new CUSIP number for the Company's Class A ordinary shares will be G67927114. Upon the effectiveness of the Reverse Share Split, every ten shares of the Company's issued and outstanding Class A ordinary shares as of the effective date will automatically be combined into one Class A ordinary share. This adjustment will reduce the total number of outstanding Class A ordinary shares of the Company from approximately 18.1 million to approximately 1.81 million. In conjunction with the Reverse Share Split, the Company also amended its Memorandum of Association to proportionately reduce the number of authorized shares for issuance and to adjust the par value of the post-reverse share split ordinary shares to $0.001 per share.The Reverse Share Split is part of the Company's efforts to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) related to the minimum bid price of at least $1.00 per share of the Company's ordinary shares.

07:54 EST American Airlines nationwide groundstop canceled, FAA reports - The FAA reported that a nationwide groundstop put in place by American Airlines earlier has been canceled. Reference Link

07:25 EST Enanta to appeal ruling related to '953 patent infringement lawsuit - Enanta Pharmaceuticals (ENTA) announced that the United States District Court of Massachusetts has issued a ruling on a summary judgment motion filed by Pfizer (PFE) in connection with Enanta's patent infringement lawsuit seeking damages for infringement of U.S. Patent No. 11,358,953 in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid. The Court issued a summary judgment decision granting Pfizer's motion that the '953 Patent is invalid. In its decision, the Court also denied Enanta's partial motion for summary judgment of infringement as moot in light of its allowance of summary judgment on invalidity. Enanta plans to appeal the decision to the Court of Appeals for the Federal Circuit.

07:10 EST American Airlines down 3% after groundstop notice issued - Shares of American Airlines are down 47c, or 3%, to $16.78 in pre-market trading after the FAA reported on a nationwide groundstop put in place by the airline that appears related to a technical issue with all American Airlines flights.

07:05 EST Sachem Capital announces repayment, delisting of unsecured unsubordinated notes - Sachem Capital reminds holders that its 6.875% unsecured, unsubordinated Notes due December 30, 2024, ticker symbol "SACC," will mature on December 30, 2024, as scheduled. The company will redeem the Notes at par plus accrued and unpaid interest up to, but not including, the maturity date.

07:02 EST Webuy achieves 'milestone' Disney cruise sales with Micky1.0 - Webuy Global announced the "success" of its recent Disney cruise campaign, powered by its Micky1.0 Travel AI on WhatsApp. The company said, " The Disney cruise campaign leveraged Webuy's digital marketing expertise to direct leads to Micky1.0, the Company's AI-powered travel assistant. Micky1.0 efficiently answered customer inquiries, provided real-time quotes, and tailored recommendations, before transferring qualified leads to travel consultants for deal closure. This streamlined process highlights the synergy between advanced technology and human expertise. From December 10th to 23rd,2024, the Disney campaign exclusively drove the following financial achievements: Receivable Booking Value: SGD 465,527; Booking Revenue: SGD 162,202. As Webuy continues to grow its travel services, the Company remains committed to integrating cutting-edge AI technologies like Micky1.0 with its core offerings, paving the way for future success in the Southeast Asian market and beyond."

06:56 EST Clearmind Medicine receives IRB approval for Phase I/IIa trial of CMND-100 - Clearmind Medicine announced it has received Institutional Review Board approval for its Phase I/IIa clinical trial of CMND-100, targeting alcohol use disorder. The trial will be led at Yale School of Medicine's Department of Psychiatry by Dr. Anahita Bassir Nia, MD, an expert in psychiatry and addiction medicine. This milestone marks a significant step forward in Clearmind's FDA-regulated clinical program, further expanding the multi-site trial to evaluate the safety, tolerability and efficacy of its proprietary investigational drug, CMND-100.

06:20 EST Netflix sues Broadcom's VMware over violation of patent rights - Netflix (NFLX) is suing Broadcom (AVGO) claiming the company's cloud computing subsidiary VMware violated its patent rights in 'virtual machines' that run another computer's operating software on a host computer, according to the suit. The suit said VMware's cloud software infringes five Netflix patents on aspects of operating virtual machines. Reference Link

06:05 EST U.K. DOT launches consultation on transition to zero emission vehicles - U.K.'s Department of Transportation Transport Secretary Heidi Alexander has launched a consultation to ask views from industry on how to deliver on the manifesto commitment to restore the 2030 phase out date for new purely petrol and diesel cars and make the transition to zero emissions vehicles a success. The 2030 phase out date was broadly supported by industry before the previous UK government extended the phase out to 2035. Currently more than two-thirds of car manufacturers in the UK, including Nissan (NSANY), Ford (F), and Stellantis (STLA), have already committed to fully transitioning to electric cars by 2030. "Today's consultation will restore clarity for vehicle manufacturers and the charging industry so that they have the confidence to invest in the UK in the long-term and drive growth in the UK automotive industry," UK's DOT said.

06:02 EST Equinix to acquire BT Group's data center business in Ireland - BT Group (BTGOF) and Equinix (EQIX) announced Monday that Equinix has agreed to acquire BT's datacentre business in Ireland, which includes two datacentres in CityWest and Ballycoolin, Dublin. The EUR 59M transaction is expected to complete during the first half of 2025, subject to competition and regulatory clearance. The transaction follows a review of assets in Ireland and includes two optimally located, well-invested, and carrier-neutral facilities of approximately 150,000 gross square feet combined, a highly experienced team, and global as well as Irish customers. BT's asset-light strategy internationally includes a transition away from owning and operating datacentre facilities, towards partnering with globally scaled organisations. This asset-light strategy and partnership approach for datacentre services gives BT a much more commercially scalable and flexible model that delivers multiple benefits to customers with services available in over 560 locations worldwide. In the coming months, Equinix will support the transition of the datacentres from BT, ensuring uninterrupted operations to customers and positioning the facilities as integral parts of Equinix's global network. Reference Link

05:58 EST Anaergia to supply organic waste to energy solution to PepsiCo in Colombia - Anaergia announced that its Canadian subsidiary, Anaergia DB, has entered into an integrated technology supply contract with PepsiCo Alimentos to provide its high-efficiency digestion technology and integrated biogas conditioning and upgrading technology at PepsiCo's (PEP) food production facility in Funza, part of the Metropolitan Area of Bogota, Colombia. The biogas system supplied by Anaergia will convert approximately 50,000 tons per year of organic residues produced at the facility into renewable natural gas to be used within the facility, offsetting the use of fossil natural gas from the grid and reducing greenhouse gas emissions by up to 3,700 tons per year of CO2.

05:54 EST Baiyu Holdings launches business of dismantling of used cars in U.S. - Baiyu Holdings has dispatched a professional operating team to launch a business in the dismantling of used cars and the sales of auto parts in the United States. The market size of the automotive dismantling and parts remanufacturing industry in the United States reaches hundreds of billions of USD, presenting tremendous development potential. In the automotive aftermarket, 80% of the parts are remanufactured components, occupying a significant position in the market.

05:28 EST DexCom, Abbott agree to settle patent litigation - In a regulatory filing, DexCom (DXCM) stated: "As previously disclosed, DexCom has been involved in global patent litigation with Abbott Diabetes Care and its affiliates. Both the Company and Abbott have accused the other of infringing certain patents, and each party has filed counterclaims and actions to invalidate the other party's patents. On December 20, the Company and Abbott entered into a settlement and patent cross license agreement to resolve all outstanding patent litigation between the parties. Under the terms of the Agreement, the Company granted Abbott and its affiliates, and Abbott and its affiliates granted the Company and its affiliates, a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation. The Agreement does not obligate the Company or Abbott to pay any royalties or any other form of financial compensation. As part of the Agreement, each party, on behalf of itself and its affiliates, has also entered into a covenant not to sue until December 20, 2034; and agreed on behalf of themselves and their affiliates to refrain from challenging the patents and patent applications licensed under the Agreement for periods of time which vary depending on the relevant patents or patent applications." Reference Link